Wikidata

(Q40571040)

English

Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro

scientific article published on April 2004

In more languages

Statements

title
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
author name string
Glen S Germain
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
Franklin C Harwood
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
John D Schuetz
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
Clinton F Stewart
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
Elisabeth Buchdunger
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
Peter Traxler
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
publication date
1 April 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017
page(s)
2333-2337
1 reference
stated in
Europe PubMed Central
PubMed ID
15059881
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40571040&oldid=1900644329"